MarketInOut Stock Screener Log In | Sign Up
 

AEON Biopharma Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/02/2026
AEON Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization15.15 mln
Float37.57 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

1.52
Transformational upside

Relative Strength

95 / 100
Top performer

ROE

204
Extraordinary

ROA

-674
Deeply negative

Business Description

AEON Biopharma is a California-based medical company working to bring new treatments to patients suffering from serious and often overlooked conditions. Its main focus is a drug called prabotulinumtoxinA, a form of botulinum toxin being studied for conditions such as cervical dystonia, chronic migraine, gastroparesis, and post-traumatic stress disorder. The company operates through partnerships with Daewoong Pharmaceutical and Viatris to advance its clinical programs.

Key Fundamentals

EPS-4.55
ROE204
ROIC-530
ROA-674
EBITDA, mln-19.82
EV / EBITDA-0.76
EV / EBIT-0.75

Quote Details

Last 0.279
Change -0.011 (-3.79%)
Open 0.30
Volume 3,204,361
Turnover 894,017
Average Volume 17,742,274

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price1.52
Short Ratio0.19
Short % of Float7.85

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.84% 93 / 100   
1 Month 2.95% 79 / 100   
2 Months -61.36% 4 / 100   
6 Months -68.61% 5 / 100   
1 Year -65.12% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us